Clinical Trial Update: A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating PEG-somatropin injections for children with Turner syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• PEG-somatropin (pegylated somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Turner Syndrome | Phase 2 | Status: UNKNOWN